These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6271833)

  • 1. Selective and potent analgetics derived from cannabinoids.
    Johnson MR; Melvin LS; Althuis TH; Bindra JS; Harbert CA; Milne GM; Weissman A
    J Clin Pharmacol; 1981; 21(S1):271S-282S. PubMed ID: 6271833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent analgetics derived from 9-nor-9 beta-hydroxyhexahydrocannabinol.
    Johnson MR; Althuis TH; Bindra JS; Harbert CA; Melvin LS; Milne GM
    NIDA Res Monogr; 1981 Feb; 34():68-74. PubMed ID: 6111753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity.
    Melvin LS; Milne GM; Johnson MR; Wilken GH; Howlett AC
    Drug Des Discov; 1995 Nov; 13(2):155-66. PubMed ID: 8872458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonantradol: a role for central prostanoid mechanisms?
    Milne GM; Johnson MR
    J Clin Pharmacol; 1981; 21(S1):367S-374S. PubMed ID: 6271837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model.
    Howlett AC; Johnson MR; Melvin LS; Milne GM
    Mol Pharmacol; 1988 Mar; 33(3):297-302. PubMed ID: 3352594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific and potent analgetic activity for nantradol--a structurally novel, cannabinoid-related analgetic.
    Milne GM; Koe BK; Johnson MR
    NIDA Res Monogr; 1979; 27():84-92. PubMed ID: 121368
    [No Abstract]   [Full Text] [Related]  

  • 7. Some 9-hydroxycannabinoid-like compounds. Synthesis and evaluation of analgesic and behavioral properties.
    Wilson RS; May EL; Dewey WL
    J Med Chem; 1979 Jul; 22(7):886-8. PubMed ID: 448688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereochemical requirements for cannabimimetic activity.
    Mechoulam R; Lander N; Srebnik M; Breuer A; Segal M; Feigenbaum JJ; Jarbe TU; Consroe P
    NIDA Res Monogr; 1987; 79():15-30. PubMed ID: 3125475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cannabinoid derived prototypical analgesic.
    Melvin LS; Johnson MR; Harbert CA; Milne GM; Weissman A
    J Med Chem; 1984 Jan; 27(1):67-71. PubMed ID: 6690685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
    Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
    J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antinociceptive effects of intrathecally administered cannabinoids are influenced by lipophilicity.
    Lichtman AH; Smith PB; Martin BR
    Pain; 1992 Oct; 51(1):19-26. PubMed ID: 1454400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levonantradol, a potent cannabinoid-related analgesic, antagonizes haloperidol-induced activation of striatal dopamine synthesis.
    Koe BK
    Eur J Pharmacol; 1981 Mar; 70(2):231-5. PubMed ID: 6266845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the role of the phenolic hydroxyl in cannabinoid activity.
    Reggio PH; Seltzman HH; Compton DR; Prescott WR; Martin BR
    Mol Pharmacol; 1990 Dec; 38(6):854-62. PubMed ID: 2174506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rational search for the separation of psychoactivity and analgesia in cannabinoids.
    Reggio PH; McGaughey GB; Odear DF; Seltzman HH; Compton DR; Martin BR
    Pharmacol Biochem Behav; 1991 Nov; 40(3):479-86. PubMed ID: 1806940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 9-Nor-9-hydroxyhexahydrocannabinols. Synthesis, Some behavioral and analgesic properties, and comparison with the tetrahydrocannabinols.
    Wilson RS; May EL
    J Med Chem; 1976 Sep; 19(9):1165-7. PubMed ID: 978681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabimimetic activity of novel enantiomeric, benzofuran cannabinoids.
    Mechoulam R; Breuer A; Järbe TU; Hiltunen AJ; Glaser R
    J Med Chem; 1990 Mar; 33(3):1037-43. PubMed ID: 2155318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological potency of R- and S-3'-hydroxy-delta 9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity.
    Martin BR; Kallman MJ; Kaempf GF; Harris LS; Dewey WL; Razdan RK
    Pharmacol Biochem Behav; 1984 Jul; 21(1):61-5. PubMed ID: 6087379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice.
    Darmani NA
    Pharmacol Biochem Behav; 2001 Feb; 68(2):311-7. PubMed ID: 11267636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of the orientation of the C9 substituent to cannabinoid activity.
    Reggio PH; Greer KV; Cox SM
    J Med Chem; 1989 Jul; 32(7):1630-5. PubMed ID: 2738895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.